. A) Analysis of the effect of mSmo expression levels on activity of mSmo deletion constructs. Amounts of DNA (w/w) used, from left to right are 1%, 3%, 10%, 25% and 50%. Horizontal lines indicate 50% (light green), 75% (green) and 100% (dark green) activity relative to 1% wt mSmo. B) Expression of membrane-tethered mSmo C-terminal cytoplasmic domain (myr-mSmoC) does not activate the mammalian Hh pathway in s4
. A) Analysis of the effect of mSmo expression levels on activity of mSmo deletion constructs. Amounts of DNA (w/w) used, from left to right are 1%, 3%, 10%, 25% and 50%. Horizontal lines indicate 50% (light green), 75% (green) and 100% (dark green) activity relative to 1% wt mSmo. B) Expression of membrane-tethered mSmo C-terminal cytoplasmic domain (myr-mSmoC) does not activate the mammalian Hh pathway in s4
Smo-/-cells lacking mSmo. Inset shows western blot of expression of two myr-mSmoC constructs of different lengths in COS1 cells. C) Mutation of dSmo isoleucine 586 to alanine decreases dSmo expression levels in Drosophila Kc cells. Expression of the dSmo constructs was monitored using constructs where dSmo was fused to Renilla luciferase. D) Expression level of mSmo in NIH-3T3 cells transfected with 0% (endogenous), 1%, 3%, 10%, 25% and 50% w/w mSmo expression construct DNA. Cells were cotransfected with GFP expression construct to monitor transfection efficiency. Inset (bottom right) shows the similar distribution of Smo in transfected cells (green/yellow) and in cells expressing endogenous Smo. Figure S2 . Conservation of mouse Kif27 and Kif7 and D. melanogaster and A. gambiae Cos2 analyzed by multiple sequence alignment (ClustalW). Yellow boxes indicate the N4-base, N1-Ploop, N2-switch and N3-switch motifs involved in ATP binding and conformational switching. Three other motifs absolutely conserved in the kinesin family, including two regions involved in microtubule binding (M1 and M2) are also indicated (white boxes). Sequence identity, similarity and conservation of hydrophilicity/hydrophobicity are indicated by asterisk, colon and period, respectively. Residues that contacts ATP are also indicated (#). Note that whereas Kif27 and Kif7 conform to the kinesin consensus, both insect Cos2 orthologues have diverged significantly in all absolutely conserved kinesin motifs. Note that the motor-domains of the insect Cos2 proteins have diverged significantly from their mammalian counterparts. Both Kif27 and Kif7 motor domains are conserved in the ATP-binding, switch and microtubule binding-domains, and include clear N4-base, N1-P-loop, N2-switch1 and N3-switch2 motifs and the microtubule binding motifs M1 and M2 (Block, 1998) . No alterations are observed in residues that are conserved in all kinesin motor domains (KISc, conserved domain cd00106.3). In contrast, both fly and mosquito Cos2 genes lack discernible N2-switch1 motif, and contain four and five mutations, respectively, in residues that are absolutely conserved in the other nucleotide binding and switch motifs in all other kinesin motor domains. These mutations also affect the ATP binding site at the N4-base motif. Thus, vertebrate Cos2 homologs have characteristics of microtubule-dependent molecular motors, whereas insect Cos2 proteins have significantly diverged from the kinesin family, losing several characteristics typical for kinesins, possible due to their adaptation for regulation of the Hh pathway. Further evidence for divergence is that the Cos2 binding regions of Ci (Wang and Jiang, 2004) are not conserved in GLIs 1-3, displaying only 9.5-20% sequence identity, compared to 24-26% average sequence identity, and 70-90% identity in the Su(Fu) binding region between Ci and GLIs 1-3. GLI2 transcriptional activity. Experiments were performed essentially as described in Fig. 3 and 4 of main text. Inset in (C): A pull-down western-blot analysis from 293T cells co-expressing HIS-tagged GLI1 together with zKif7 or human Su(Fu). Note that whereas Su(Fu) associates with GLI1, zKif7 does not. These results are in contrast to Tay et al. (Tay et al., 2005) , who observed binding of zKif7 to GLI1 when these proteins are overexpressed in 293T cells (which are not responsive to Hh). Tay et al. (Tay et al., 2005) also reported that injection of Zebrafish with Kif7 'morpholino' antisense oligonucleotides cause a phenotype consistent with weak Hh pathway activation (9 of 16 injected embryos display a minor increase in Ptc expression). In our hands, RNAi of Kif7 or Kif27 do not affect Shh pathway activity (Fig. 5C, D) , and neither zKif7, mouse Kif7 nor Kif27 bind to GLI proteins (inset in C and not shown), affect GLI2 transcriptional activity (C, Fig. 4D , E) or nuclear localization of GLI2 or GLI3 in Hh responsive cells (A, B, Fig. 5A ). In addition, expression of Drosophila Cos2 in mouse cells has no effect on Shh pathway activity (Fig. 3C ) or on GLI2 transcriptional activity (Fig. 3D ). Hh-related phenotypes can be observed in Zebrafish by morpholino-mediated targeting of genes (Wilbanks et al., 2004) whose loss in mice does not result in an obvious Hh-related phenotype (Bohn et al., 1999) . Because of the clear divergence between Hh signaling Drosophila and mouse, it is possible that the differences between our results and (Tay et al., 2005) are similarly due to differences between fish and mouse (see Bohn et al., 1999; Wilbanks et al., 2004) . Although gain-of-function experiments presented above, unlike loss-of-function studies, are not subject to false negative results due to redundancy, they are sometimes considered unreliable because of off-target or non-specific results due to high expression levels (false positive results). However, since in our case we see no effect of overexpression of mouse Cos2 homologs, the sensitivity of the gain-of-function method actually makes our results more, not less, reliable. In order to be consistent with the experiments presented here, the view of conservation of mechanism at the level of Cos2 and Smo would require that the binding surfaces between Cos2 and Smo, and Cos2 and Ci/GLI both have diverged in such a way that Drosophila and mouse proteins do not bind to each other ( Fig. 3C; Fig. 3D ). At the same time, the phosphorylation sites and Cos2 binding domain in Drosophila would have moved to a different site in mSmo ( Fig. 2; Fig. 3C ). Together with the increased importance of Su(Fu) in mammals (Fig. 5) this non-parsimonious model would actually constitute an argument for significant divergence, and is still inconsistent with the lack of effect of mouse Cos2 homologs on GLI nuclear localization or transcriptional activity (e.g. Figs 
Supplemental Experimental Procedures

RNAi and cDNA Expression Constructs
Full length mouse Kif27 and Su(Fu), and cargo domains of Kif3a (amino-acids 529-702; accession BC052707), Kif7 (1022-1329; XM_133575), and Kif27 (1050-1395; NM_175214) were cloned from mouse embryo PCR-ready cDNA (Ambion) using Phusion (Finnzymes) or Taq (Roche) DNA polymerase. Kif3a, Kif4, Kif5B, Kif17, Kif21A, and Kif23 cDNA-expression constructs were from Origene (Rockville, MD, USA). For western blotting, cDNAs were cloned to pcDNA-3.1-V5/HIS vector (Invitrogen) containing a V5 tag. An untagged Kif27 construct in pcDNA3.1-Hygro+ (Invitrogen) was used for reporter assays (see below). mSmo point mutations and deletions were introduced to the C-terminally triple-myc-tagged pGE-mSmo (Taipale et al., 2002) expression construct using PCR. Constructs fusing mouse Smo amino-acids 1-637 to Drosophila Smo C-terminal region (aa 652-1036; m-dSmo junction AIL-GAAT) were generated by PCR using wild type Drosophila Smo (in Smo/w, Fig 3C) , and Smo all PKA + III, V, VI, VIII Ala (inactive dSmo; in Smo/i) and Glu (hyperactive dSmo; in Smo/a) (Zhang et al., 2004) . Nterminal myristoylation sequence from c-Src was fused (Jia et al., 2003) to the cytoplasmic tail of mSmo to generate pGE-mtSmoC-myc3. An AseI-MluI expression cassette derived from this construct based on CMV promoter (resulting in general expression; Feil et al., 1996; Schneider et al., 2000) was used to generate transgenic mouse embryos. Genotyping was performed using the primers TGGAGGCGCACCTGGTGCA and AGCTGAGGGTTCATTGAGGTC. All constructs were sequence verified.
pActinSV-Cos2, pCMV-Cos2, pActinSV-Ci and pActinSV-Renilla were a kind gift from Dr. Lawrence Lum, Dsh-myc construct was from Dr. Jeremy Nathans (Johns Hopkins University, Maryland, USA), and mouse GLI2-GFP and human GLI3-GFP constructs were from Prof. Rune Toftgård (Karolinska Institutet, Stockholm). The GLI-GFP fusions are transcriptionally active, and similarly to wild-type GLI3 (Wang et al., 2000) , the GLI3-GFP fusion protein is processed to a repressor form in COS1 cells treated with forskolin (not shown).
Human H1 promoter driven shRNA (Brummelkamp et al., 2002) vector pSilencer3.0-H1 (Ambion) was used for RNA interference analyses. To select shRNAs, we used three criteria: 1) thermodynamic analysis (Khvorova et al., 2003; Schwarz et al., 2003) to find shRNAs which are predicted to be active, 2) the mfold RNA folding algorithm (Zuker, 2003) to find target sites which are not predicted to have a very stable secondary structure (i.e. stem-loop; target sequences are > 55% single stranded on average in 50 best RNA-folding models), 3) BLAST (word size = 17) analysis to find target sequences which were only found in the target gene and not in any other ENSEMBL30/NCBIm30 mouse transcript (to decrease the probability of off-target effects). The following 21 bp target sequences were selected: GLI2 (XM_136212; first nucleotides for constructs 1 to 5: 3271, 3514, 3272, 3598, 269), mSmo (XM_133018; 2130 , 1608 , 2309 , 1063 , 1219 1752 , 1753 , Ptc (NM_008957; 2828), Su(Fu) (AF134893; 740, 546, 583), Kif4 (NM_008446; 2761 , 1904 314, 102), Kif7 (XM_133575; 254, 2947 , 2414 2179 , 2922 82, 1047), Kif27 (NM_175214; 1005 , 1135 , 2095 ), and APC (NM_007462, 1915 , 2186 .
A dsDNA oligonucleotide with a 5' BamHI site, an 19 bp sequence containing bases 3-21 of the selected target sequence, loop TTCAAGAGA, reverse complement of the 21 bp sequence, a transcriptional terminator TTTTTTGGAA and a 3' HindIII site were ligated to pSilencer3.0-H1 according to manufacturers instructions (Ambion). Efficiency of the shRNA constructs were verified by co-transfecting them (90% w/w of DNA) into NIH-3T3 cells with a firefly luciferase transfection control reporter (5% w/w DNA, pGL3-control, Promega) and the following constructs (5% w/w DNA) containing the target sequences and a C-terminal Renilla luciferase: mSmo-Renilla, Ptc-Renilla, Su(Fu)-Renilla, Kif4(1904 Kif4( -1924 Efficiency of RNAi was measured as a ratio of relative luciferase activities (ratio of Renilla luciferase to firefly luciferase) of tested dsRNA to control dsRNA measured after 2d of incubation (Dual Luciferase kit, Promega). This analysis is expected to underestimate the efficiency of suppression of endogenous mRNAs, as the target mRNAs are expressed approx. 2-10-fold above endogenous levels (see (Taipale et al., 2002) and Figure S1D ).
Immunoprecipitation
For immunoprecipitation, cells were lysed into a buffer containing 0.5% NP-40, 50 mM Tris-Cl pH 7.5, 150 mM NaCl, 50 mM NaF, 1 mM Na 3 VO 4 , 100 µg/ml leupeptin and 50 µg/ml AEBSF, and the lysates centrifuged at 16 200 x g for 25 min. Lysates were then precleared by incubation with Protein A Sepharose beads (Amersham) at +4°C for 2 h, followed by centrifugation at 16 200 x g for 15 min. Supernatants were incubated with anti-myc antibodies (A14) overnight, and the immune complexes collected by the addition of Protein A Sepharose beads. The beads were washed four times with the lysis buffer, and the precipitated proteins were analyzed by reducing 7.5% SDS-PAGE (Criterion, Bio-Rad) followed by western blotting using monoclonal antibodies directed against the myc (9E10) and V5 (46-0705) tags. Binding of Drosophila Cos2 from wild type S2 cell lysate to GST-fusion proteins containing dSmo cytoplasmic tails (with or without I586A mutation) were performed similarly to the method described above, except that Glutathione-Sepharose beads and monoclonal antibodies against Cos2 were used in precipitation and immunoblotting, respectively. The polyclonal antibody A14 was used for western-blotting analysis of myc-tagged mSmo constructs expressed in COS1 cells. Molecular mass marker was from Bio-Rad laboratories (Precision+ protein all blue 10-250 kDa). In all cases, equal loading of the gels was verified by Poinceau Red staining of the membranes prior to western blotting.
